{"transactions":[{"id":2277784,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-09T16:16:03.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":233705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying this option shall vest and become exercisable on March 4, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":233705,"derivative":{"exercise_price":3.33,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":233705},"source":{"system":"sec-edgar","filing":"0001104659-22-057525","document":"tm2214815-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057525/tm2214815-3_4seq1.xml","form_type":"4"}},{"id":2277783,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-05-09T16:16:03.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":233705,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."},{"field":"shares","element":"transactionShares","label":"F3","text":"25% of these RSUs shall vest on April 1, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."}],"balance_after":256437,"source":{"system":"sec-edgar","filing":"0001104659-22-057525","document":"tm2214815-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057525/tm2214815-3_4seq1.xml","form_type":"4"}},{"id":2277782,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-05-09T16:16:03.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":22732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."},{"field":"shares","element":"transactionShares","label":"F2","text":"These RSUs vest in full on February 7, 2023, subject to the reporting person's continued service at such time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."}],"balance_after":22732,"source":{"system":"sec-edgar","filing":"0001104659-22-057525","document":"tm2214815-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057525/tm2214815-3_4seq1.xml","form_type":"4"}},{"id":3888599,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, CCO & Corporate Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T23:06:25.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on June 15, 2019.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001638599-18-000679","document":"doc4_5478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859918000679/doc4_5478.xml","form_type":"4"}},{"id":4163603,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC, CCO & Corporate Secretary"}}],"security":"Common  Stock","published_at":"2017-11-15T02:58:48.000Z","date":"2017-11-14","kind":"purchase","acquired":true,"shares":5405,"price":9.25,"value":49996.25,"ownership":{"direct":true},"balance_after":5405,"source":{"system":"sec-edgar","filing":"0001638599-17-001136","document":"doc4_5077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917001136/doc4_5077.xml","form_type":"4"}},{"id":4259036,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and Corporate Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-11T20:42:53.000Z","date":"2017-07-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on June 16, 2018.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":19.33,"expiration_date":"2027-07-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001638599-17-000697","document":"doc4_4849.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000163859917000697/doc4_4849.xml","form_type":"4"}},{"id":4512561,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO, Gen.Counsel, Corp.Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-23T19:19:53.000Z","date":"2016-12-21","kind":"exercise","acquired":false,"shares":12280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are fully vested."}],"balance_after":540,"derivative":{"exercise_price":0.47,"expiration_date":"2019-07-23","underlying":"Common Stock","underlying_shares":12280},"source":{"system":"sec-edgar","filing":"0001104659-16-163717","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916163717/a4.xml","form_type":"4"}},{"id":4512560,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO, Gen.Counsel, Corp.Sec."}}],"security":"Common Stock","published_at":"2016-12-23T19:19:53.000Z","date":"2016-12-21","kind":"sale","acquired":false,"shares":14844,"price":18,"value":267192.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-16-163717","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916163717/a4.xml","form_type":"4"}},{"id":4512559,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":127485,"kind":"person","name":"Abraham David","position":1,"cik":"0001676903","reported_name":"Abraham David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO, Gen.Counsel, Corp.Sec."}}],"security":"Common Stock","published_at":"2016-12-23T19:19:53.000Z","date":"2016-12-21","kind":"exercise","acquired":true,"shares":12280,"price":0.47,"value":5771.6,"ownership":{"direct":true},"balance_after":14844,"source":{"system":"sec-edgar","filing":"0001104659-16-163717","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1453687/000110465916163717/a4.xml","form_type":"4"}}]}